Andrea Antinori

Biographic Data

ID7733232
NAMEAndrea Antinori
GIVEN NAMESAndrea
FAMILY NAMEAntinori
SIGNATUREANTINORI A
AFFILIATIONSIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
ORCID0000-0003-2121-4684
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
AUTHOR COUNT8
EDITOR COUNT0
FIRST PUBLICATION YEAR2002
LATEST PUBLICATION YEAR2023
H-INDEX0

  • Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy

    Antonella Cingolani, Alessandro Tavelli et al.ARTICLEAIDS Care2023

    Evidences on the absence of risk of sexual transmission of HIV by persons living with HIV/AIDS (PLWHA) with undetectable plasma HIV-RNA (HIV-RNA <200 copies/ml) led to the worldwide campaign "U = U" (undetectable = untransmittable). The purpose of this study was to evaluate the perceived accuracy of this message among PLWHA, HIV-negative people having unprotected sex (PHUS) and infectious diseases' (ID) physicians in Italy. A nationwide survey ha…

  • Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

    John P Thornhill, John Thornhill et al.ARTICLENew England Journal of Medicine2022

    BACKGROUND: Before April 2022, monkeypox virus infection in humans was seldom reported outside African regions where it is endemic. Currently, cases are occurring worldwide. Transmission, risk factors, clinical presentation, and outcomes of infection are poorly defined. METHODS: We formed an international collaborative group of clinicians who contributed to an international case series to describe the presentation, clinical course, and outcomes o…

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER)

    Open AccessAlec Rodger, Alison J Rodger et al.ARTICLEThe Lancet2019

    BACKGROUND: The level of evidence for HIV transmission risk through condomless sex in serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral therapy (ART) is limited compared with the evidence available for transmission risk in heterosexual couples. The aim of the second phase of the PARTNER study (PARTNER2) was to provide precise estimates of transmission risk in gay serodifferent partnerships. METHODS:…

  • Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients

    Open AccessLewis Haddow, Lewis J Haddow et al.ARTICLEAIDS and Behavior2017

    We conducted a cross-sectional study in 448 HIV positive patients attending five European outpatient clinics to determine prevalence of and factors associated with neurocognitive impairment (NCI) using computerized and pen-and-paper neuropsychological tests. NCI was defined as a normalized Z score ≤-1 in at least 2 out of 5 cognitive domains. Participants' mean age was 45.8 years; 84% male; 87% white; 56% university educated; median CD4 count 550…

  • Discrepancies between physician's perception of depression in HIV patients and self-reported CES-D-20 assessment

    F Marando, Giuliana Gualberti et al.ARTICLEAIDS Care2016

    Depression in HIV/AIDS patients affects adherence and disease progression and often goes unnoticed. DHIVA is a cross-sectional epidemiologic survey, investigating the prevalence of depression in people living with HIV through use of a validated self-administered scale (CES-D-20), as well and the degree of concordance between the physician's perception and patients' reports. A total of 690 HIV-infected patients attending 24 centers across Italy we…

  • Updated research nosology for HIV-associated neurocognitive disorders

    Open AccessAndrea Antinori, Gabriele Arendt et al.ARTICLENeurology2007

    In 1991, the AIDS Task Force of the American Academy of Neurology published nomenclature and research case definitions to guide the diagnosis of neurologic manifestations of HIV-1 infection. Now, 16 years later, the National Institute of Mental Health and the National Institute of Neurological Diseases and Stroke have charged a working group to critically review the adequacy and utility of these definitional criteria and to identify aspects that …

  • Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Persons

    Open AccessAdriana Ammassari, Andrea Antinori et al.ARTICLEPsychosomatics2004

  • Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy

    Adriana Ammassari, Maria Paola Trotta et al.ARTICLEJAIDS Journal of Acquired Immune…2002

    Knowledge of factors associated with medication adherence could help HIV clinicians to target persons in need of intervention, design these interventions, and help researchers to plan studies of adherence. This review summarizes the results of 20 studies investigating the issue of barriers to optimal highly active antiretroviral therapy (HAART) adherence. Only a few determinants were consistently associated with nonadherence. Symptoms and adverse…